Literature DB >> 11591429

Reduced olfactory performance in patients with major depression.

B M Pause1, A Miranda, R Göder, J B Aldenhoff, R Ferstl.   

Abstract

The aim of the present study is to investigate olfactory sensitivity and odor evaluations in a homogeneous sample of unipolar depressive patients using pure olfactory odors. Twenty-four in-patients with major depressive disorder (MDD) were investigated during their acute depressive phase. Eighteen of them participated a second time after successful treatment. A group of healthy subjects, matched by age, sex, and smoking behavior, served as a control. Olfactory sensitivity, as measured by threshold tests, was strongly reduced in patients with severe depression. Additional correlative analyses revealed that the lowered sensitivity could partly be predicted by high depression scores. After successful medical treatment, these sensitivity differences were reduced and did not reach the significance level. The subjective odor evaluations (valence and intensity ratings) were not markedly changed in general. The results reveal that olfactory performance in MDD patients is reduced at an early perceptional level of stimulus processing. It is discussed whether this effect can be attributed to the close functional connection between the main olfactory bulb and the amygdala.

Entities:  

Mesh:

Year:  2001        PMID: 11591429     DOI: 10.1016/s0022-3956(01)00029-2

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  64 in total

Review 1.  Cortical odor processing in health and disease.

Authors:  Donald A Wilson; Wenjin Xu; Benjamin Sadrian; Emmanuelle Courtiol; Yaniv Cohen; Dylan C Barnes
Journal:  Prog Brain Res       Date:  2014       Impact factor: 2.453

Review 2.  Olfaction as a marker for depression.

Authors:  Ilona Croy; Thomas Hummel
Journal:  J Neurol       Date:  2016-07-08       Impact factor: 4.849

3.  A Nose for Seizures: A Potential Role for Olfaction in the Co-Morbidity of Depression and Epilepsy?

Authors:  Catherine A Christian
Journal:  Epilepsy Curr       Date:  2016 Jul-Aug       Impact factor: 7.500

4.  Psychophysiological and electrophysiological testing of olfactory and gustatory function in patients with multiple sclerosis.

Authors:  Sarah Bettina Dahlslett; Oender Goektas; Felix Schmidt; Lutz Harms; Heidi Olze; Franca Fleiner
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-11-06       Impact factor: 2.503

5.  Molecular connectivity disruptions in males with major depressive disorder.

Authors:  Rajapillai Li Pillai; Mengru Zhang; Jie Yang; J John Mann; Maria A Oquendo; Ramin V Parsey; Christine DeLorenzo
Journal:  J Cereb Blood Flow Metab       Date:  2018-03-09       Impact factor: 6.200

6.  Factors Associated with Inaccurate Self-Reporting of Olfactory Dysfunction in Older US Adults.

Authors:  Dara R Adams; Kristen E Wroblewski; David W Kern; Michael J Kozloski; William Dale; Martha K McClintock; Jayant M Pinto
Journal:  Chem Senses       Date:  2017-03-01       Impact factor: 3.160

7.  A Free-breathing fMRI Method to Study Human Olfactory Function.

Authors:  Jianli Wang; Sebastian Rupprecht; Xiaoyu Sun; Diana Freiberg; Courtney Crowell; Emma Cartisano; Megha Vasavada; Qing X Yang
Journal:  J Vis Exp       Date:  2017-07-30       Impact factor: 1.355

8.  Gustatory and olfactory function in breast cancer patients.

Authors:  Silke Steinbach; Walter Hundt; Thomas Zahnert; Sabina Berktold; Christina Böhner; Nina Gottschalk; Moritz Hamann; Monika Kriner; Petra Heinrich; Barbara Schmalfeldt; Nadia Harbeck
Journal:  Support Care Cancer       Date:  2009-06-03       Impact factor: 3.603

9.  Neuroleptic-induced parkinsonism is associated with olfactory dysfunction.

Authors:  Stephanie Krüger; Antje Haehner; Claudia Thiem; Thomas Hummel
Journal:  J Neurol       Date:  2008-09-03       Impact factor: 4.849

Review 10.  Altered taste and stroke: a case report and literature review.

Authors:  Tara M Dutta; Anne F Josiah; Carolyn A Cronin; George F Wittenberg; John W Cole
Journal:  Top Stroke Rehabil       Date:  2013 Jan-Feb       Impact factor: 2.119

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.